Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

JSON

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Maturi NP, Haglund C, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, Uhrbom L

Cell Rep 19 (5) 1080-1081 [2017-05-02; online 2017-05-04]

Drug Discovery and Development (DDD) [Service]

PubMed 28467901

DOI 10.1016/j.celrep.2017.04.053

Crossref 10.1016/j.celrep.2017.04.053

pii: S2211-1247(17)30564-8